A Case report of atovaquone/proguanil induced esophageal ulcers

2020 ◽  
Vol 27 (7) ◽  
Author(s):  
Luisa Carnino ◽  
Christian Hulo ◽  
Giacomo Puppa ◽  
Djanwai Berenger Konan ◽  
François Chappuis

A case report of atovaquone/proguanil esophageal ulcer.

2018 ◽  
Vol 12 (5) ◽  
pp. 309-314 ◽  
Author(s):  
Zhaohui Bai ◽  
Xiaozhong Guo ◽  
Xiaodong Shao ◽  
Yingying Li ◽  
Qianqian Li ◽  
...  

2018 ◽  
Vol 50 (4) ◽  
pp. e363
Author(s):  
P. Gaio ◽  
L. Bosa ◽  
S. Rossin ◽  
V. Buccella ◽  
L. Nai Fovino ◽  
...  

2014 ◽  
Vol 18 (3) ◽  
pp. 156-158
Author(s):  
Seher Sayın ◽  
Ruhuşen Kutlu ◽  
Serhat Sayın ◽  
Hüseyin Ataseven

Endoscopy ◽  
1993 ◽  
Vol 25 (07) ◽  
pp. 482-483
Author(s):  
B. Zipprich ◽  
R. Heine ◽  
H.-F. Gerlach

1992 ◽  
Vol 14 (2) ◽  
pp. 148-151
Author(s):  
Shotaro Nakamura ◽  
Mitsuo Iida ◽  
Norio Kohrogi ◽  
Atsuko Shimizu ◽  
Seizaburo Kashiwagi ◽  
...  
Keyword(s):  

1998 ◽  
Vol 116 (6) ◽  
pp. 1882-1884 ◽  
Author(s):  
Angelo Paulo Ferrari Junior ◽  
Sérgio Hernani Stuhr Domingues

OBJECTIVE: To describe a case of esophageal ulcer associated with the use of alendronate. CASE REPORT: This is the fifth case ever described in the literature according to our bibliographic review. In our patient, the association between the drug and the esophageal lesions was masked by the presence of a hiatal hernia, potentially a cause of the esophageal lesion. The persistence of the lesions despite high doses of anti-reflux therapy called attention to the possibility of the relationship. The esophageal lesion healed soon after suspension of alendronate. DISCUSSION: The authors present a review of the literature and point to the need for diagnostic investigation, to suspend such a drug from patients who experience dyspeptic symptoms while using it.


Sign in / Sign up

Export Citation Format

Share Document